Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel, Double Blind Study of Losartan Versus Amlodipine in Patients With Mild to Moderate Hypertension and Chronic Nondiabetic Proteinuric Nephropathy: Evaluation of the Effect on Proteinuria and on the Plasmatic Levels of Growth Factors (TGFß and VEGF)

NCT00140985 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00140985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel, Double Blind Study of Losartan Versus Amlodipine in Patients With Mild to Moderate Hypertension and Chronic Nondiabetic Proteinuric Nephropathy: Evaluation of the Effect on Proteinuria and on the Plasmatic Levels of Growth Factors (TGFß and VEGF)
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2000
Completion date
January 31, 2002
Enrollment
97 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal disorder